Investigating digoxin's effects on infants with heart failure from congenital heart disease
Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease
This study is looking at how the heart medicine digoxin works in babies with heart failure caused by a specific heart condition, hoping to find better ways to help these little ones feel better and live healthier lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10807963 on NIH RePORTER |
What this research studies
This research focuses on understanding how the drug digoxin works in infants suffering from heart failure due to single ventricle congenital heart disease. It aims to address the critical lack of effective heart failure treatments for this vulnerable population by studying how digoxin is processed in their bodies and how it affects their heart function. The study will involve careful monitoring of drug levels and heart performance in these infants to identify the best therapeutic approaches. By filling the knowledge gaps in pediatric heart failure treatment, this research hopes to improve survival rates and quality of life for affected infants.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants diagnosed with single ventricle congenital heart disease who are experiencing heart failure.
Not a fit: Patients with heart failure due to other causes or those who are older than infancy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and survival rates for infants with heart failure due to congenital heart disease.
How similar studies have performed: Previous studies have shown promising results with digoxin in similar populations, but this specific approach to understanding its pharmacodynamics in infants is novel.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Hornik, Christoph — Duke University
- Study coordinator: Hornik, Christoph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.